Intrathecal sensory neuron-specific receptor agonists bovine adrenal medulla 8-22 and (Tyr6)-γ2-msh-6-12 inhibit formalin-evoked nociception and neuronal Fos-like immunoreactivity in the spinal cord of the rat

Neuroscience

Volumn 141, Issue 2, 2006, Pages 965-975

  Chen, T ^a   Cai, Q ^a   Hong, Y ^a  

^a FUJIAN NORMAL UNIVERSITY   (China)

Author keywords

(Tyr6) 2 MSH 6 12; bovine adrenal medulla 8 22; c Fos; formalin test; sensory neuron specific receptor

Indexed keywords

BOVINE ADRENAL MEDULLA 8-22 PEPTIDE; FORMALDEHYDE; NALOXONE; PEPTIDE; PROTEIN FOS; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ADRENAL MEDULLA; ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; IMMUNOREACTIVITY; LICKING; MALE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SPINAL CORD; SPINAL CORD DORSAL HORN;

ANIMALS; BEHAVIOR, ANIMAL; CATTLE; DIOCTYL SULFOSUCCINIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GAMMA-MSH; IMMUNOHISTOCHEMISTRY; MALE; NALOXONE; NEURONS, AFFERENT; PAIN MEASUREMENT; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, G-PROTEIN-COUPLED; SPINAL CORD;

EID: 33746001396     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.04.011     Document Type: Article

References (61)

1. Abbadie C., Taylor B.K., Peterson M.A., and Basbaum A.I. Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord. studies with remifentanil and lidocaine. Pain 69 (1997) 101-110
2. Akopian A.N., Souslova V., England S., Okuse K., Ogata N., Ure J., Smith A., Kerr B.J., McMahon S.B., Boyce S., Hill R., Stanfa L.C., Dickenson A.H., and Wood J.N. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 2 (1999) 541-548
3. Bao J., Li J.J., and Perl E.R. Differences in Ca2+ channels governing generation of miniature and evoked excitatory synaptic currents in spinal laminae I and II. J Neurosci 18 (1998) 8740-8750
4. Bardin L., Assie M.B., Pelissou M., Royer-Urios I., Newman-Tancredi A., Ribet J.P., Sautel F., Koek W., and Colpaert F.C. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]. relationship with 5-HT1A receptor occupancy and kinetic parameters. J Pharmacol Exp Ther 312 (2005) 1034-1042
5. Beland B., and Fitzgerald M. Mu- and delta-opioid receptors are downregulated in the largest diameter primary sensory neurons during postnatal development in rats. Pain 90 (2001) 143-150
6. Besson J.M., and Chaouch. Peripheral and spinal mechanisms of nociception. Physiol Rev 67 (1987) 67-186
7. Bomholt S.F., Mikkelsen J.D., and Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 48 (2005) 252-263
8. Bonnefont J., Chapuy E., Clottes E., Alloui A., and Eschalier. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats. effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 114 (2005) 482-490
9. Bourgoin S., Le Bars D., Clot A.M., Hamon M., and Cesselin F. Subcutaneous formalin induces a segmental release of Met-enkephalin-like material from the rat spinal cord. Pain 41 (1990) 323-329
10. Buritova J., and Besson J.M. Effects of nefopam on the spinal nociceptive processes. a c-Fos protein study in the rat. Eur J Pharmacol 441 (2002) 67-74
11. Burnstock G. P2X receptors in sensory neurones. Br J Anaesth 84 (2000) 476-488
12. Caterina M.J., and Julius D. The vanilloid receptor. a molecular gateway to the pain pathway. Annu Rev Neurosci 24 (2001) 487-517
13. Chen H., and Ikeda S.R. Modulation of ion channels and synaptic transmission by a human sensory neuron-specific G-protein-coupled receptor, SNSR4/mrgX1, heterologously expressed in cultured rat neurons. J Neurosci 24 (2004) 5044-5053
14. Coderre T.J., and Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12 (1992) 3665-3670
15. Coderre T.J., Vaccarino A.L., and Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 535 (1990) 155-158
16. Dib-Hajj S.D., Tyrrell L., Cummins T.R., Black J.A., Wood P.M., and Waxman S.G. Two tetrodotoxin-resistant sodium channels in human dorsal root ganglion neurons. FEBS Lett 462 (1999) 117-120
17. Dores R.M., McDonald L.K., Steveson T.C., and Sei C.A. The molecular evolution of neuropeptides. prospects for the '90s. Brain Behav Evol 36 (1990) 80-99
18. Dubuisson D., and Dennis S.G. The formalin test. a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4 (1977) 161-174
19. Fjell J., Hjelmstrom P., Hormuzdiar W., Milenkovic M., Aglieco F., Tyrrell L., Dib-Hajj S., Waxman S.G., and Black J.A. Localization of the tetrodotoxin-resistant sodium channel NaN in nociceptors. Neuroreport 11 (2000) 199-202
20. Genzen J.R., Van Cleve W., and McGehee D.S. Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes. J Neurophysiol 86 (2001) 1773-1782
21. Gogas K.R., Cho H.J., Botchkina G.I., Levine J.D., and Basbaum A.I. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine. Pain 65 (1996) 9-15
22. Grazzini E., Puma C., Roy M.O., Yu X.H., O'Donnell D., Schmidt R., Dautrey S., Ducharme J., Perkins M., Panetta R., Laird J.M., Ahmad S., and Lembo P.M. Sensory neuron-specific receptor activation elicits central and peripheral nociceptive effects in rats. Proc Natl Acad Sci U S A 101 (2004) 7175-7180
23. Gu J.G., and MacDermott A.B. Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature 389 (1997) 749-753
24. Harris J.A. Using c-fos as a neural marker of pain. Brain Res Bull 45 (1998) 1-8
25. Hong Y., and Abbott F.V. Peripheral opioid modulation of pain and inflammation in the formalin test. Eur J Pharmacol 277 (1995) 21-28
26. Hong Y., Dai P., Jiang J., and Zeng X. Dual effects of intrathecal BAM22 on nociceptive responses in acute and persistent pain-potential function of a novel receptor. Br J Pharmacol 141 (2004) 423-430
27. Hunskaar S., and Hole K. The formalin test in mice. dissociation between inflammatory and non-inflammatory pain. Pain 30 (1987) 103-114
28. Jhamandas K.H., Sutak M., and Henderson G. Antinociceptive and morphine modulatory actions of spinal orphanin FQ. Can J Physiol Pharmacol 76 (1998) 314-324
29. Ji R.R., Zhang Q., Law P.Y., Low H.H., Elde R., and Hokfelt T. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 15 (1995) 8156-8166
30. Julius D., and Basbaum A.I. Molecular mechanisms of nociception. Nature 413 (2001) 203-210
31. Kaneko M., Mestre C., Sanchez E.H., and Hammond D.L. Intrathecally administered gabapentin inhibits formalin-evoked nociception and the expression of Fos-like immunoreactivity in the spinal cord of the rat. J Pharmacol Exp Ther 292 (2000) 743-751
32. Kawamura M., Ohara H., Go K., Koga Y., and Ienaga K. Neurotropin induces antinociceptive effect by enhancing descending pain inhibitory systems involving 5-HT3 and noradrenergic alpha2 receptors in spinal dorsal horn. Life Sci 62 (1998) 2181-2190
33. Khachaturian H., Lewis M.E., and Watson S.J. Colocalization of proenkephalin peptides in rat brain neurons. Brain Res 279 (1983) 369-373
34. Labuz D., Chocyk A., Wedzony K., Toth G., and Przewlocka B. Endomorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord. Life Sci 73 (2003) 403-412
35. Lembo P.M., Grazzini E., Groblewski T., O'Donnell D., Roy M.O., Zhang J., Hoffert C., Cao J., Schmidt R., Pelletier M., Labarre M., Gosselin M., Fortin Y., Banville D., Shen S.H., Strom P., Payza K., Dray A., Walker P., and Ahmad S. Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat Neurosci 5 (2002) 201-209
36. Li D.P., Chen S.R., Pan Y.Z., Levey A.I., and Pan H.L. Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol 543 (2002) 807-818
37. Millan M.J. The induction of pain. an integrative review. Prog Neurobiol 57 (1999) 1-164
38. Millan M.J., and Colpaert F.C. Opioid systems in the response to inflammatory pain. sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology. Neuroscience 42 (1991) 541-553
39. Murray C.W., and Cowan A. Tonic pain perception in the mouse. differential modulation by three receptor-selective opioid agonists. J Pharmacol Exp Ther 257 (1991) 335-341
40. Ossipov M.H., Kovelowski C.J., Wheeler-Aceto H., Cowan A., Hunter J.C., Lai J., Malan Jr. T.P., and Porreca F. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin. demonstration of an opioid kappa and delta inhibitory tone. J Pharmacol Exp Ther 277 (1996) 784-788
41. Pittius C.W., Seizinger B.R., Pasi A., Mehraein P., and Herz. Distribution and characterization of opioid peptides derived from proenkephalin A in human and rat central nervous system. Brain Res 304 (1984) 127-136
42. Porro C.A., and Cavazzuti M. Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model. Prog Neurobiol 41 (1993) 565-607
43. Presley R.W., Menetrey D., Levine J.D., and Basbaum A.I. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci 10 (1990) 323-335
44. Snider W.D., and McMahon S.B. Tackling pain at the source. new ideas about nociceptors. Neuron 20 (1998) 629-632
45. Stoyanova I., Dandov A., Lazarov N., and Chouchkov C. GABA- and glutamate-immunoreactivity in sensory ganglia of cat. a quantitative analysis. Arch Physiol Biochem 106 (1998) 362-369
46. Stucky C.L., and Lewin G.R. Isolectin B(4)-positive and -negative nociceptors are functionally distinct. J Neurosci 19 (1999) 6497-6505
47. Svensson C.I., and Yaksh T.L. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 42 (2002) 553-583
48. Tate S., Benn S., Hick C., Trezise D., John V., Mannion R.J., Costigan M., Plumpton C., Grose D., Gladwell Z., Kendall G., Dale K., Bountra C., and Woolf C.J. Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons. Nat Neurosci 1 (1998) 653-655
49. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., and Hole K. The formalin test. an evaluation of the method. Pain 51 (1992) 5-17
50. Wang H., and Wessendorf M.W. Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J Comp Neurol 429 (2001) 590-600
51. Waxman S.G., Cummins T.R., Dib-Hajj S., Fjell J., and Black J.A. Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain. Muscle Nerve 22 (1999) 1177-1187
52. Wheeler-Aceto H., and Cowan. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology (Berl) 104 (1991) 35-44
53. Wheeler-Aceto H., Porreca F., and Cowan. The rat paw formalin test. comparison of noxious agents. Pain 40 (1990) 229-238
54. Willis W.D., and Westlund K.N. Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 14 (1997) 2-31
55. Wu H.E., Hung K.C., Mizoguchi H., Nagase H., and Tseng L.F. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin. J Pharmacol Exp Ther 300 (2002) 647-654
56. Yaksh T.L., and Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17 (1976) 1031-1036
57. Yamamoto T., Nozaki-Taguchi N., and Kimura S. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test. Neuroscience 81 (1997) 249-254
58. Yamamoto T., and Yaksh T.L. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 77 (1992) 757-763
59. Zeng X., Huang H., and Hong Y. Effects of intrathecal BAM22 on noxious stimulus-evoked c-fos expression in the rat spinal dorsal horn. Brain Res 1028 (2004) 170-179
60. Zhao C.S., Tao Y.X., Tall J.M., Donovan D.M., Meyer R.A., and Raja S.N. Role of micro-opioid receptors in formalin-induced pain behavior in mice. Exp Neurol 184 (2003) 839-845
61. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110